Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis
A Standard patent application filed on 17 September 1998 credited to Glenn, Kevin
;
Needleman, Philip
Details
Application number :
92317
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis
Inventor :
Glenn, Kevin
;
Needleman, Philip
Agent name :
E F Wellington & Co
Address for service :
312 St Kilda Road MELBOURNE VIC 3006
Filing date :
17 September 1998
Associated companies :
Applicant name :
Pharmacia Corporation
Applicant address :
800 North Lindberg Boulevard, St. Louis, Missouri 63167, United States Of America